Advertisement

Reactions Weekly

, Volume 1739, Issue 1, pp 109–109 | Cite as

Dasabuvir/ombitasvir/paritaprevir/ritonavir

Alanine aminotransferase elevation and drug resistance: 4 case reports
Case report
  • 8 Downloads

Reference

  1. Puigvehi M, et al. Eight weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV genotype 1b with mild-moderate fibrosis: Results from a real-world cohort. Liver International 39: 90-97, No. 1, Jan 2019. Available from: URL: http://doi.org/10.1111/liv.13950 - SpainCrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations